Treatment of gastroesophageal reflux disease based on "Stagnation, Depression, Stasis and Deficiency theory"
-
-
[1] Solomon GD. Gastroesophageal Reflux Disease[J]. Ann Intern Med, 2015, 163: 959. doi: 10.7326/L15-5180
[2] 周金池, 赵曙光, 王新, 等. 中国部分地区基于社区人群胃食管反流病患病率Meta分析[J]. 胃肠病学和肝病学杂志, 2020, 29(9): 1012-1020. doi: 10.3969/j.issn.1006-5709.2020.09.012
[3] 魏玮, 荣培晶, 陈建德, 等. 虚、滞、瘀、郁——现代慢性疾病中医病机新认知[J]. 中国中西医结合杂志, 2020, 40(10): 1264-1267. doi: 10.7661/j.cjim.201912006.301
[4] 张声生, 朱生樑, 王宏伟, 等. 胃食管反流病中医诊疗专家共识意见(2017)[J]. 中国中西医结合消化杂志, 2017, 25(5): 321-326. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXPW201705001.htm
[5] Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal Reflux Disease: A Review[J]. JAMA, 2020, 324(24): 2536-2547. doi: 10.1001/jama.2020.21360
[6] Katzka DA, Kahrilas PJ. Advances in the diagnosis and management of gastroesophageal reflux disease[J]. BMJ, 2020, 371: 3786.
[7] 中华医学会消化病学分会. 2020年中国胃食管反流病专家共识[J]. 中华消化杂志, 2020, 40(10): 649-663. doi: 10.3760/cma.j.cn311367-20200918-00558
[8] Nguyen PA, Islam M, Galvin CJ, et al. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia[J]. Int J Qual Health Care, 2020, 32(5): 292-299. doi: 10.1093/intqhc/mzaa041
[9] Eusebi LH, Rabitti S, Artesiani ML, et al. Proton pump inhibitors: Risks of long-term use[J]. J Gastroenterol Hepatol 2017;32(7): 1295-1302. doi: 10.1111/jgh.13737
[10] Dunbar KB, Agoston AT, Odze RD, et al. Association of acute gastroesophageal reflux disease with esophageal histologic changes[J]. JAMA, 2016, 315: 2104-2112. doi: 10.1001/jama.2016.5657
[11] 周金池, 窦维佳, 魏延, 等. 中国胃食管反流病患者焦虑抑郁患病率的Meta分析[J]. 中国全科医学, 2021, 24(5): 608-613. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202105018.htm
[12] 吾布力卡斯木·吾拉木, 买买提·依斯热依力, 克力木·阿不都热依木. 慢性束缚应激对小鼠食管内脏敏感性的影响及其诱导食管炎症和氧化应激的作用[J]. 中华医学杂志, 2019, 34(2): 135-141.
[13] Wong MW, Liu TT, Yi CH, et al. Oesophageal hypervigilance and visceral anxiety relate to reflux symptom severity and psychological distress but not to acid reflux parameters[J]. Aliment Pharmacol Ther, 2021, 54(7): 923-930. doi: 10.1111/apt.16561
[14] Kessing BF, Bredenoord AJ, Saleh CM, et al. Effects of anxiety and depression in patients with gastroesophageal reflux disease[J]. Clin Gastroenterol Hepatol, 2015, 13(6): 1089-1095. doi: 10.1016/j.cgh.2014.11.034
[15] Iyer PG, Kaul V. Barrett Esophagus[J]. Mayo Clin Proc, 2019, 94(9): 1888-1901. doi: 10.1016/j.mayocp.2019.01.032
[16] Yuan LZ, Yi P, Wang G, et al. Lifestyle intervention for gastroesophageal reflux disease: a national multicenter survey of lifestyle factor effects on gastroesophageal reflux disease in China. [J]. Therap Adv Gastroenterol, 2019, 12: 1756284819877788.
[17] Tack J, Pandolfino JE. Pathophysiology of Gastroesophageal Reflux Disease[J]. Gastroenterology, 2018, 154(2): 277-288. doi: 10.1053/j.gastro.2017.09.047
[18] 谭珍媛, 邓家刚, 张彤, 等. 中药厚朴现代药理研究进展[J]. 中国实验方剂学杂志, 2020, 26(22): 228-234. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202022030.htm
[19] 李陈雪, 杨玉赫, 冷德生, 等. 枳壳化学成分及药理作用研究进展[J]. 辽宁中医药大学学报, 2019, 21(2): 158-161. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB201902046.htm
[20] 王欣. 辛开苦降方治疗反流性食管炎与胃肠激素GAS、MOT、SP表达的相关性研究[D]. 北京: 北京中医药大学, 2015.
[21] 李依洁, 王燕丽, 魏玮. 辛开苦降法治疗胃食管反流病随机对照试验系统评价与Meta分析[J]. 世界中西医结合杂志, 2015, 10(11): 1490-1495. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZX201511004.htm
[22] 林彤, 彭立生. 基于网络药理学和分子对接探讨肿节风的活性成分及药效机制[J]. 中医药导报, 2020, 26(11): 106-111. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZB202011028.htm
[23] 王艳杰, 杨彦娟, 康芯荣, 等. 白花蛇舌草、半枝莲药对及其不同提取部位抗肿瘤作用的实验研究[J]. 中华中医药学刊, 2020, 38(10): 105-109, 282-283. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202010024.htm
-
计量
- 文章访问数: 785
- PDF下载数: 467
- 施引文献: 0
下载: